|
Market Closed -
Japan Exchange
01:30:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 2,696.00 JPY | -5.54% |
|
-1.61% | +2.59% |
| 10-05 | ROHTO Pharmaceutical Co., Ltd. Revises Earnings Guidance for the Fiscal Year 2031 | CI |
| 10-05 | ROHTO Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Fiscal Year 2026, 2029 and 2032 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.85B | |||||
| 1,206B | |||||
| 665B | |||||
| 515B | |||||
| 381B | |||||
| 362B |
Select your edition
All financial news and data tailored to specific country editions
